Rafael Marcos‐Gragera

25.1k total citations · 2 hit papers
174 papers, 4.6k citations indexed

About

Rafael Marcos‐Gragera is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Rafael Marcos‐Gragera has authored 174 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 43 papers in Pathology and Forensic Medicine and 42 papers in Epidemiology. Recurrent topics in Rafael Marcos‐Gragera's work include Global Cancer Incidence and Screening (57 papers), Lymphoma Diagnosis and Treatment (29 papers) and Colorectal Cancer Screening and Detection (27 papers). Rafael Marcos‐Gragera is often cited by papers focused on Global Cancer Incidence and Screening (57 papers), Lymphoma Diagnosis and Treatment (29 papers) and Colorectal Cancer Screening and Detection (27 papers). Rafael Marcos‐Gragera collaborates with scholars based in Spain, Italy and United Kingdom. Rafael Marcos‐Gragera's co-authors include Otto Visser, Roberta De Angelis, Milena Sant, Marc Maynadié, Claudia Allemani, Carmen Ţereanu, Jaume Galcerán, Riccardo Capocaccia, Carmen Navarro and Arianna Simonetti and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rafael Marcos‐Gragera

165 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

2010 665 citations Milena Sant, Claudia Allemani et al. profile →
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

2014 373 citations Annalisa Trama, Carmen Navarro et al. Cancer Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael Marcos‐Gragera Spain	32	2.3k	1.0k	917	728	688	174	4.6k
Claudia Allemani United Kingdom	28	2.3k 1.0×	801 0.8×	731 0.8×	551 0.8×	467 0.7×	84	4.3k
Roberta De Angelis Italy	34	3.3k 1.4×	1.0k 1.0×	1.2k 1.3×	921 1.3×	517 0.8×	100	6.0k
Pierre Soubeyran France	42	2.7k 1.2×	2.4k 2.3×	1.3k 1.4×	368 0.5×	1.3k 1.8×	195	7.2k
Séamus O’Reilly Ireland	35	3.9k 1.7×	1.6k 1.6×	1.2k 1.3×	401 0.6×	572 0.8×	227	6.8k
Jean-Philippe Jaı̈s France	36	1.2k 0.6×	1.3k 1.3×	566 0.6×	594 0.8×	543 0.8×	138	4.8k
Bhawna Sirohi India	33	1.7k 0.7×	431 0.4×	792 0.9×	384 0.5×	312 0.5×	171	3.8k
Ronald S. Go United States	44	2.5k 1.1×	1.7k 1.6×	752 0.8×	533 0.7×	1.4k 2.0×	362	7.3k
Ephraim P. Hochberg United States	42	1.9k 0.8×	2.0k 1.9×	410 0.4×	266 0.4×	1.2k 1.8×	148	5.2k
Wayne L. Furman United States	43	1.9k 0.8×	539 0.5×	1.1k 1.2×	392 0.5×	386 0.6×	197	6.1k
Gloria Broadwater United States	42	3.1k 1.4×	592 0.6×	1.0k 1.1×	405 0.6×	428 0.6×	182	6.2k

Countries citing papers authored by Rafael Marcos‐Gragera

Since Specialization

Citations

This map shows the geographic impact of Rafael Marcos‐Gragera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Marcos‐Gragera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Marcos‐Gragera more than expected).

Fields of papers citing papers by Rafael Marcos‐Gragera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Marcos‐Gragera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Marcos‐Gragera. The network helps show where Rafael Marcos‐Gragera may publish in the future.

Co-authorship network of co-authors of Rafael Marcos‐Gragera

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Marcos‐Gragera. A scholar is included among the top collaborators of Rafael Marcos‐Gragera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Marcos‐Gragera. Rafael Marcos‐Gragera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Botta, Laura, Riccardo Capocaccia, Alice Bernasconi, et al.. (2025). The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation. American Journal of Epidemiology. 194(11). 3316–3324.

Crocetti, Emanuele, Damien Bennett, Valérie Jooste, et al.. (2025). Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study. European Journal of Cancer. 231. 116061–116061. 1 indexed citations

Morgan, Eileen, Murielle Colombet, Eva Steliarova‐Foucher, et al.. (2024). Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022. Leukemia. 39(2). 412–419. 10 indexed citations

Petrova, Dafina, Daniel Redondo‐Sánchez, Miguel Rodríguez‐Barranco, et al.. (2024). Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain. BMJ Quality & Safety. 34(12). 810–823. 1 indexed citations

Bouvier, Anne‐Marie, Valérie Jooste, Roberto Lillini, et al.. (2024). Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries. International Journal of Cancer. 155(5). 807–815. 7 indexed citations

Botta, Laura, Riccardo Capocaccia, Alice Bernasconi, et al.. (2024). Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers. European Journal of Cancer. 208. 114187–114187. 4 indexed citations

Giusti, Francesco, Carmen Martos, Annalisa Trama, et al.. (2023). Cancer treatment data available in European cancer registries: Where are we and where are we going?. Frontiers in Oncology. 13. 1109978–1109978. 15 indexed citations

Gómez‐Acebo, Inés, Javier Llorca, Jéssica Alonso-Molero, et al.. (2023). Circulating miRNAs signature on breast cancer: the MCC-Spain project. European journal of medical research. 28(1). 480–480. 2 indexed citations

Sant, Milena, Andrea Maurichi, Roberto Lillini, et al.. (2022). Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations. Cancers. 14(18). 4379–4379. 2 indexed citations

10.

Peremiquel‐Trillas, Paula, Laia Alemany, Alberto Ameijide, et al.. (2022). Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age–Period–Cohort Modelling. International Journal of Environmental Research and Public Health. 19(3). 1404–1404. 7 indexed citations

11.

Rubió‐Casadevall, Jordi, et al.. (2018). Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994–2013: a population-based study. Clinical & Translational Oncology. 20(12). 1617–1625. 8 indexed citations

12.

Solans, Marta, Gemma Osca‐Gelis, R. Comas, et al.. (2018). Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer Causes & Control. 29(3). 379–382. 8 indexed citations

13.

Botta, Laura, Riccardo Capocaccia, Annalisa Trama, et al.. (2018). Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiology. 54. 95–100. 7 indexed citations

14.

Roca-Barceló, Aina, Gemma Viñas, Anna Carbó, et al.. (2018). Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994–2013). Clinical & Translational Oncology. 21(7). 891–899. 3 indexed citations

15.

Rubió‐Casadevall, Jordi, et al.. (2016). Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study. Cancer Epidemiology. 45. 6–10. 42 indexed citations

16.

Sánchez, María‐José, A. Torrella-Ramos, Carmen Martos, et al.. (2013). Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study. Gynecologic Oncology. 130(3). 609–614. 53 indexed citations

17.

Zwan, Jan Maarten van der, Annalisa Trama, R. Otter, et al.. (2013). Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project. European Journal of Cancer. 49(11). 2565–2578. 87 indexed citations

18.

Salmerón, Diego, María‐Dolores Chirlaque, M. Isabel Izarzugaza, et al.. (2012). Lung cancer prognosis in Spain: The role of histology, age and sex. Respiratory Medicine. 106(9). 1301–1308. 49 indexed citations

19.

Feja, Cristina, et al.. (2010). DESIGUALDADES GEOGRÁFICAS EN MORTALIDAD E INCIDENCIA POR CÁNCER DE LARINGE EN VARONES: FACTORES SOCIOECONÓMICOS Y AMBIENTALES. SHILAP Revista de lepidopterología. 2 indexed citations

20.

Marcos‐Gragera, Rafael, Sílvia de Sanjosé, Carlota Calvo, et al.. (2010). Population-based incidence of childhood leukaemias and lymphomas in Spain (1993–2002). European Journal of Cancer Prevention. 19(4). 247–255. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact